Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. (Nasdaq: HSAQ) is a healthcare-focused special purpose acquisition company that completed its initial public offering in 2020, targeting opportunities in the life sciences and biomedical sector. The company filed a Form 10-Q with the Securities and Exchange Commission on November 5, 2020, accession number 0001213900-20-035161, reflecting its financial position during the search phase for a qualifying business combination. HSAQ was structured to pursue targets within the medical device and therapeutic innovation space, consistent with its registered identity as a blank check company organized under Delaware law. For complete sponsor details, deal timeline, warrant structure, and comparable SPAC analytics, sign up for full access at SpacDesk.